Cargando…
General intelligence in adult patients with early- and adult-onset schizophrenia
INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core fea...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434486/ http://dx.doi.org/10.1192/j.eurpsy.2023.1048 |
_version_ | 1785091901881319424 |
---|---|
author | Calkova, T. Mørch-Johnsen, L. Elle Smelror, R. Nordbø Jørgensen, K. Cervenka, S. Collste, K. Vaskinn, A. Margrethe Myhre, A. Andreassen, O. A. Ueland, T. Agartz, I. Andreou, D. |
author_facet | Calkova, T. Mørch-Johnsen, L. Elle Smelror, R. Nordbø Jørgensen, K. Cervenka, S. Collste, K. Vaskinn, A. Margrethe Myhre, A. Andreassen, O. A. Ueland, T. Agartz, I. Andreou, D. |
author_sort | Calkova, T. |
collection | PubMed |
description | INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core feature of schizophrenia, accounting for a large part of the detrimental effect of the disorder and may reflect underlying neurodevelopmental disturbances. Some but not all previous studies show that the magnitude of cognitive deficits, including intelligence quotient (IQ), in patients with schizophrenia is dependent on the age of onset. OBJECTIVES: We aimed to assess IQ in adult patients with EOS and AOS, and healthy controls. We hypothesized that patients with EOS would show lower IQ than those with AOS, and both patient groups lower IQ than HC. METHODS: We included 136 adult patients with EOS (mean age: 24.7 (7.7) years, mean duration of illness: 9.3 (8.5) years, 50% women), 382 patients with AOS (mean age: 32.4 (9.5) years, mean duration of illness: 5.7 (6.6) years, 40.1% women) and 896 adult healthy controls (mean age: 33.2 (9.2) years, 47.1% women). We assessed current IQ with the Wechsler Abbreviated Scale of Intelligence (WASI) which yielded verbal (VIQ), performance (PIQ) and full-scale IQ (FIQ) scores. In a post-hoc analysis, we estimated premorbid IQ using the National Adult Reading Test (NART). We applied analyses of covariance (ANCOVAs) to investigate the putative differences in IQ scores and IQ change between patients with EOS, patients with AOS and healthy controls. RESULTS: In sex-, and age-adjusted models, FIQ and PIQ, but not VIQ, were significantly lower in EOS than in AOS (p=0.03, p<0.001 and p=0.428, respectively) (Image). Patients with EOS had fewer years of education than patients with AOS (p<0.001); the PIQ but not the FIQ difference between EOS and AOS remained significant after adjustment for education years (p=0.016 and p=0.333, respectively). Both patient groups had significantly lower IQ scores than healthy controls (Image). Further, patients with EOS and patients with AOS did not significantly differ in estimated premorbid IQ (109 and 110 units, respectively, p=0.092), whereas patients with EOS had a significantly larger estimated IQ decline after the disease onset compared to patients with AOS (12 and 9 units decline, respectively, p=0.015). Image: CONCLUSIONS: Our findings show that adult patients with EOS have significantly lower PIQ and FIQ scores, and significantly larger IQ decline after the disease onset, but not lower premorbid IQ, compared to patients with AOS. The adolescent onset of psychotic symptoms is linked, as expected, to fewer total years of education, which appears to explain the lower FIQ but only partially the lower PIQ in EOS, which may thereby be linked to the disorder per se. DISCLOSURE OF INTEREST: T. Calkova: None Declared, L. Mørch-Johnsen: None Declared, R. Elle Smelror: None Declared, K. Nordbø Jørgensen: None Declared, S. Cervenka: None Declared, K. Collste: None Declared, A. Vaskinn: None Declared, A. Margrethe Myhre: None Declared, O. A. Andreassen Consultant of: HealthLytix, Speakers bureau of: Lundbeck and Sunovion, T. Ueland: None Declared, I. Agartz: None Declared, D. Andreou: None Declared |
format | Online Article Text |
id | pubmed-10434486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104344862023-08-18 General intelligence in adult patients with early- and adult-onset schizophrenia Calkova, T. Mørch-Johnsen, L. Elle Smelror, R. Nordbø Jørgensen, K. Cervenka, S. Collste, K. Vaskinn, A. Margrethe Myhre, A. Andreassen, O. A. Ueland, T. Agartz, I. Andreou, D. Eur Psychiatry Abstract INTRODUCTION: Early-onset schizophrenia (EOS) is a relatively uncommon disorder with psychotic symptoms emerging before 18 years of age. Although still under debate, EOS may be a more severe disorder relative to adult-onset schizophrenia (AOS), with worse prognosis. Cognitive deficits are a core feature of schizophrenia, accounting for a large part of the detrimental effect of the disorder and may reflect underlying neurodevelopmental disturbances. Some but not all previous studies show that the magnitude of cognitive deficits, including intelligence quotient (IQ), in patients with schizophrenia is dependent on the age of onset. OBJECTIVES: We aimed to assess IQ in adult patients with EOS and AOS, and healthy controls. We hypothesized that patients with EOS would show lower IQ than those with AOS, and both patient groups lower IQ than HC. METHODS: We included 136 adult patients with EOS (mean age: 24.7 (7.7) years, mean duration of illness: 9.3 (8.5) years, 50% women), 382 patients with AOS (mean age: 32.4 (9.5) years, mean duration of illness: 5.7 (6.6) years, 40.1% women) and 896 adult healthy controls (mean age: 33.2 (9.2) years, 47.1% women). We assessed current IQ with the Wechsler Abbreviated Scale of Intelligence (WASI) which yielded verbal (VIQ), performance (PIQ) and full-scale IQ (FIQ) scores. In a post-hoc analysis, we estimated premorbid IQ using the National Adult Reading Test (NART). We applied analyses of covariance (ANCOVAs) to investigate the putative differences in IQ scores and IQ change between patients with EOS, patients with AOS and healthy controls. RESULTS: In sex-, and age-adjusted models, FIQ and PIQ, but not VIQ, were significantly lower in EOS than in AOS (p=0.03, p<0.001 and p=0.428, respectively) (Image). Patients with EOS had fewer years of education than patients with AOS (p<0.001); the PIQ but not the FIQ difference between EOS and AOS remained significant after adjustment for education years (p=0.016 and p=0.333, respectively). Both patient groups had significantly lower IQ scores than healthy controls (Image). Further, patients with EOS and patients with AOS did not significantly differ in estimated premorbid IQ (109 and 110 units, respectively, p=0.092), whereas patients with EOS had a significantly larger estimated IQ decline after the disease onset compared to patients with AOS (12 and 9 units decline, respectively, p=0.015). Image: CONCLUSIONS: Our findings show that adult patients with EOS have significantly lower PIQ and FIQ scores, and significantly larger IQ decline after the disease onset, but not lower premorbid IQ, compared to patients with AOS. The adolescent onset of psychotic symptoms is linked, as expected, to fewer total years of education, which appears to explain the lower FIQ but only partially the lower PIQ in EOS, which may thereby be linked to the disorder per se. DISCLOSURE OF INTEREST: T. Calkova: None Declared, L. Mørch-Johnsen: None Declared, R. Elle Smelror: None Declared, K. Nordbø Jørgensen: None Declared, S. Cervenka: None Declared, K. Collste: None Declared, A. Vaskinn: None Declared, A. Margrethe Myhre: None Declared, O. A. Andreassen Consultant of: HealthLytix, Speakers bureau of: Lundbeck and Sunovion, T. Ueland: None Declared, I. Agartz: None Declared, D. Andreou: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434486/ http://dx.doi.org/10.1192/j.eurpsy.2023.1048 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Calkova, T. Mørch-Johnsen, L. Elle Smelror, R. Nordbø Jørgensen, K. Cervenka, S. Collste, K. Vaskinn, A. Margrethe Myhre, A. Andreassen, O. A. Ueland, T. Agartz, I. Andreou, D. General intelligence in adult patients with early- and adult-onset schizophrenia |
title | General intelligence in adult patients with early- and adult-onset schizophrenia |
title_full | General intelligence in adult patients with early- and adult-onset schizophrenia |
title_fullStr | General intelligence in adult patients with early- and adult-onset schizophrenia |
title_full_unstemmed | General intelligence in adult patients with early- and adult-onset schizophrenia |
title_short | General intelligence in adult patients with early- and adult-onset schizophrenia |
title_sort | general intelligence in adult patients with early- and adult-onset schizophrenia |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434486/ http://dx.doi.org/10.1192/j.eurpsy.2023.1048 |
work_keys_str_mv | AT calkovat generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT mørchjohnsenl generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT ellesmelrorr generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT nordbøjørgensenk generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT cervenkas generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT collstek generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT vaskinna generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT margrethemyhrea generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT andreassenoa generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT uelandt generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT agartzi generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia AT andreoud generalintelligenceinadultpatientswithearlyandadultonsetschizophrenia |